GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Thor Medical ASA (OSTO:NANOo) » Definitions » 5-Year ROIIC %

Thor Medical ASA (OSTO:NANOO) 5-Year ROIIC % : 157.71% (As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Thor Medical ASA 5-Year ROIIC %?

5-Year Return on Invested Incremental Capital (5-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 5-year. Thor Medical ASA's 5-Year ROIIC % for the quarter that ended in Dec. 2023 was 157.71%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Thor Medical ASA's 5-Year ROIIC % or its related term are showing as below:

OSTO:NANOo's 5-Year ROIIC % is ranked better than
85.84% of 1384 companies
in the Biotechnology industry
Industry Median: -19.27 vs OSTO:NANOo: 157.71

Thor Medical ASA 5-Year ROIIC % Historical Data

The historical data trend for Thor Medical ASA's 5-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Thor Medical ASA 5-Year ROIIC % Chart

Thor Medical ASA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
5-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -451.99 -667.30 -498.15 - 157.71

Thor Medical ASA Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Dec22 Jun23 Dec23
5-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 157.71

Competitive Comparison of Thor Medical ASA's 5-Year ROIIC %

For the Biotechnology subindustry, Thor Medical ASA's 5-Year ROIIC %, along with its competitors' market caps and 5-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Thor Medical ASA's 5-Year ROIIC % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Thor Medical ASA's 5-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Thor Medical ASA's 5-Year ROIIC % falls into.



Thor Medical ASA 5-Year ROIIC % Calculation

Thor Medical ASA's 5-Year ROIIC % for the quarter that ended in Dec. 2023 is calculated as:

5-Year ROIIC %=5-Year Incremental Net Operating Profit After Taxes (NOPAT)**/5-Year Incremental Invested Capital**
=( -7.161 (Dec. 2023) - -340.8290312 (Dec. 2018) )/( 287.832 (Dec. 2023) - 76.26 (Dec. 2018) )
=333.6680312/211.572
=157.71%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Annual data of NOPAT and Invested Capital was used to calculate 5-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Thor Medical ASA  (OSTO:NANOo) 5-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Thor Medical ASA 5-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Thor Medical ASA's 5-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Thor Medical ASA (OSTO:NANOO) Business Description

Traded in Other Exchanges
Address
Kjelsasveien 168 B, Oslo, NOR, 0884
Nordic Nanovector ASA is a biopharmaceutical company. It is engaged in the development and commercialization of targeted therapeutics to improve the lives of patients with haematological cancers, such as non-Hodgkin lymphoma and leukaemia. The company's main clinical stage product is Betalutin.

Thor Medical ASA (OSTO:NANOO) Headlines

No Headlines